Table 1

Results of multivariate analysis: variables directly and inversely associated with pure motor stroke in the four logistic regression models

Variables	β	SE (β)	OR (95% CI)
Demographic data and vascular risk factors:^1-150
Hypertension	1.1942	0.1637	3.30 (2.39–4.55)
Obesity	0.8052	0.3295	2.24 (1.17–4.27)
Diabetes	0.4725	0.1798	1.60 (1.13–2.28)
Female sex	−0.3739	0.1581	0.69 (0.50–0.94)
Atrial fibrillation	−0.9531	0.2154	0.38 (0.25–0.59)
Demographic data, vascular risk factors and clinical features:^1-151
Hypertension	1.2944	0.1690	3.65 (2.62–5.08)
Non-sudden stroke onset (h)	0.6118	0.1571	1.84 (1.14–2.36)
Diabetes	0.4988	0.1854	1.65 (1.14–2.37)
Hyperlipidaemia	0.4134	0.2001	1.51 (1.02–2.23)
Speech disturbances	−0.6628	0.1617	0.51 (0.37–0.71)
Atrial fibrillation	−0.7863	0.2223	0.45 (0.29–0.70)
Headache	−0.9941	0.2651	0.37 (0.22–0.62)
Dizziness	−2.0106	0.7395	0.13 (0.03–0.57)
Demographic data, vascular risk factors, clinical features, and neuroimaging data:^1-152
Internal capsule involvement	2.7513	0.2360	15.66 (9.86–24.87)
Hypertension	1.4479	0.1875	4.25 (2.95–6.14)
Diabetes	0.6685	0.2047	1.95 (1.31–2.91)
Non-sudden stroke onset (h)	0.4397	0.1717	1.55 (1.11–2.17)
Speech disturbances	−0.7440	0.1796	0.47 (0.33–0.67)
Middle cerebral artery topography	−0.7915	0.2017	0.45 (0.30–0.67)
Headache	−1.1757	0.2788	0.31 (0.18–0.53)
Congestive heart failure	−1.5356	0.5766	0.21 (0.07–0.67)
Basal ganglia involvement	−1.9265	0.3140	0.14 (0.08–0.27)
Thalamic involvement	−2.4895	0.5340	0.08 (0.03–0.24)
Demographic data, vascular risk factors, clinical features, neuroimaging data, and outcome:^1-153
Internal capsule involvement	2.6514	0.2398	14.17 (8.86–22.68)
Hypertension	1.4829	0.1913	4.40 (3.02–6.41)
Diabetes	0.7750	0.2108	2.17 (1.44–3.28)
Pons topography	0.4370	0.3207	1.55 (0.82–2.90)
Middle cerebral artery involvement	−0.6475	0.2095	0.52 (0.35–0.79)
Speech disturbances	−0.7308	0.1834	0.48 (0.34–0.69)
Headache	−1.1022	0.2852	0.33 (0.19–0.58)
Urinary complications	−1.1058	0.3800	0.33 (0.16–0.70)
Rheumatic heart disease	−1.2722	0.7482	0.28 (0.06–1.21)
Congestive heart failure	−1.4847	0.5868	0.23 (0.07–0.72)
Cardiac events	−1.7466	0.7743	0.17 (0.04–0.80)
Neurological complications	−1.8952	0.5273	0.15 (0.05–0.42)
Thalamic involvement	−2.3771	0.5463	0.09 (0.03–0.27)

↵1-150 β=−2.6900, SE (β)=0.4971, goodness of fit χ²=8.4581, df=8, p=0.3900.
↵1-151 β=−2.4153, SE (β)=0.5368, goodness of fit χ²=12.2125, df=8, p=0.1420.
↵1-152 β=−2.1216, SE (β)=0.5944, goodness of fit χ²=8.1408, df=8, p=0.4198.
↵1-153 β=−2.2323, SE (β)=0.6102, goodness of fit χ²=9.6255, df=8, p=0.2923.